A new scoring system to predicting the survival of patients treated with whole-brain radiotherapy for brain metastases

Strahlentherapie und Onkologie

Volumn 184, Issue 5, 2008, Pages 251-255

  Rades, Dirk ^a   Dunst, Juergen ^a   Schild, Steven E ^b  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b MAYO CLINIC   (United States)

Author keywords

Brain metastases; Score; Survival; Whole brain radiotherapy

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN METASTASIS; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER SURVIVAL; COMPARATIVE STUDY; FEMALE; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PERFORMANCE; PREDICTION; PROGNOSIS; RETROSPECTIVE STUDY; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; SURVIVAL TIME; TREATMENT DURATION;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; BREAST NEOPLASMS; CRANIAL IRRADIATION; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; KARNOFSKY PERFORMANCE STATUS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; TUMOR BURDEN;

EID: 42449151738     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00066-008-1831-5     Document Type: Article

References (11)

1. Cozzi L, Clivio A, Vanetti E, et al. Comparative planning study for proton radiotherapy of benign brain tumors. Strahlenther Onkol 2006;182:376-81.
2. DeAngelis LM, Delattre JY, Posner JB. Radiation-induced dementia in patients cured of brain metastases. Neurology 1989;39:789-96.
3. Gaspar L, Scott C, Rotman M, et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 1997;37:745-51.
4. Kaplan EL, Meier P. Non parametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
5. Oertel S, Krempien R, Lindel K, et al. Human glioblastoma and carcinoma xenograft tumors treated by combined radiation and imatinib (Gleevec). Strahlenther Onkol 2006;182:400-7.
6. Penitzka S, Steinvorth S, Selleier S, et al. Assessment of cognitive function after preventive and therapeutic whole brain irradiation using neuropsychological testing. Strahlenther Onkol 2002;178:252-8.
7. Rades D, Bohlen G, Dunst J, et al. Comparison of short-course versus long-course whole-brain radiotherapy in the treatment of brain metastases. Strahlenther Onkol 2008;184:30-5.
8. Rades D, Bohlen G, Lohynska R, et al. Whole-brain radiotherapy with 20 Gy in 5 fractions for brain metastases in patients with cancer of unknown primary (CUP). Strahlenther Onkol 2007;183:631-6.
9. Rades D, Schild SE. Is 50 Gy sufficient to achieve long-term local control after incomplete resection of typical neurocytomas? Strahlenther Onkol 2006;182:415-8.
10. Schuuring J, Bussink J, Bernsen HJ, et al. Effect of carbogen breathing on the radiation response of a human glioblastoma xenograft: analysis of hypoxia and vascular parameters of regrowing tumors. Strahlenther Onkol 2006;182:408-14.
11. Sundstrom JT, Minn H, Lertola KK, et al. Prognosis of patients treated for intracranial metastases with whole-brain irradiation. Ann Med 1998;30:296-9.